Login to Your Account


Chasing improved safety and decreased brain damage for stroke sufferers, Nuvox Pharma LLC is preparing for a fourth quarter start to a phase Ib study of NVX-208, one of multiple oxygen therapeutics the company is advancing.

SHANGHAI – KBP Biosciences (China) Inc. is the brainchild of Zhenhua Huang, a Chinese serial entrepreneur that first found success with his earlier effort, Xuanzhu Pharma.

Three-year-old Rasna Therapeutics Inc. took the reverse merger route to the public markets, joining with Canadian travel company Active With Me Inc. to gain a listing on the Over-the-Counter Pink market, where it will continue to trade, for now, under the ticker ATVM.

More Newco News Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: